Norinchukin Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-20,826
| Closed | -$3.83M | – | 550 |
|
2021
Q2 | $3.83M | Buy |
20,826
+455
| +2% | +$83.6K | 0.06% | 175 |
|
2021
Q1 | $3.12M | Buy |
20,371
+979
| +5% | +$150K | 0.04% | 196 |
|
2020
Q4 | $3.03M | Sell |
19,392
-118
| -0.6% | -$18.4K | 0.04% | 180 |
|
2020
Q3 | $2.23M | Buy |
19,510
+447
| +2% | +$51.2K | 0.04% | 209 |
|
2020
Q2 | $2.14M | Sell |
19,063
-202
| -1% | -$22.7K | 0.04% | 201 |
|
2020
Q1 | $1.73M | Sell |
19,265
-10,705
| -36% | -$961K | 0.03% | 208 |
|
2019
Q4 | $3.24M | Sell |
29,970
-3,087
| -9% | -$334K | 0.04% | 238 |
|
2019
Q3 | $3.24M | Buy |
33,057
+814
| +3% | +$79.7K | 0.05% | 249 |
|
2019
Q2 | $4.22M | Sell |
32,243
-10,809
| -25% | -$1.42M | 0.06% | 187 |
|
2019
Q1 | $5.82M | Buy |
43,052
+1,548
| +4% | +$209K | 0.07% | 175 |
|
2018
Q4 | $4.04M | Buy |
41,504
+12,841
| +45% | +$1.25M | 0.06% | 205 |
|
2018
Q3 | $3.98M | Buy |
28,663
+3,453
| +14% | +$480K | 0.05% | 187 |
|
2018
Q2 | $3.13M | Buy |
25,210
+4,898
| +24% | +$608K | 0.05% | 192 |
|
2018
Q1 | $2.26M | Buy |
20,312
+2,450
| +14% | +$273K | 0.04% | 216 |
|
2017
Q4 | $2.14M | Buy |
17,862
+1,249
| +8% | +$149K | 0.04% | 220 |
|
2017
Q3 | $2.33M | Buy |
16,613
+1,029
| +7% | +$144K | 0.05% | 231 |
|
2017
Q2 | $1.9M | Buy |
15,584
+989
| +7% | +$120K | 0.04% | 259 |
|
2017
Q1 | $1.77M | Buy |
14,595
+992
| +7% | +$120K | 0.04% | 253 |
|
2016
Q4 | $1.66M | Buy |
13,603
+1,597
| +13% | +$195K | 0.04% | 248 |
|
2016
Q3 | $1.47M | Buy |
12,006
+257
| +2% | +$31.5K | 0.04% | 260 |
|
2016
Q2 | $1.37M | Buy |
11,749
+187
| +2% | +$21.8K | 0.03% | 251 |
|
2016
Q1 | $1.61M | Buy |
11,562
+1,035
| +10% | +$144K | 0.04% | 238 |
|
2015
Q4 | $2.01M | Sell |
10,527
-2,412
| -19% | -$460K | 0.05% | 183 |
|
2015
Q3 | $2.02M | Buy |
12,939
+263
| +2% | +$41.1K | 0.05% | 204 |
|
2015
Q2 | $2.29M | Buy |
12,676
+691
| +6% | +$125K | 0.06% | 180 |
|
2015
Q1 | $2.08M | Buy |
11,985
+301
| +3% | +$52.2K | 0.05% | 191 |
|
2014
Q4 | $2.16M | Buy |
11,684
+3,742
| +47% | +$692K | 0.05% | 179 |
|
2014
Q3 | $1.32M | Buy |
7,942
+561
| +8% | +$93K | 0.04% | 180 |
|
2014
Q2 | $1.15M | Sell |
7,381
-805
| -10% | -$126K | 0.03% | 179 |
|
2014
Q1 | $1.25M | Buy |
8,186
+863
| +12% | +$131K | 0.04% | 174 |
|
2013
Q4 | $973K | Sell |
7,323
-21
| -0.3% | -$2.79K | 0.03% | 195 |
|
2013
Q3 | $853K | Buy |
7,344
+585
| +9% | +$67.9K | 0.02% | 202 |
|
2013
Q2 | $623K | Buy |
+6,759
| New | +$623K | 0.02% | 222 |
|